A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Ilies Benotmane; Timothée Bruel; Delphine Planas; Samira Fafi-Kremer; Olivier Schwartz; Sophie Caillard

doi:10.1016/j.kint.2022.02.011

Journal articles

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Ilies Benotmane ¹ Timothée Bruel ^{2, 3} Delphine Planas ^{2, 3} Samira Fafi-Kremer ¹ Olivier Schwartz ^{2, 3} Sophie Caillard ¹

1 CHU Strasbourg

2 Virus et Immunité - Virus and immunity

3 VRI - Vaccine Research Institute

Abstract : Research Letter

Keywords : Delta variant SARS-CoV-2 fourth dose kidney transplantation mRNA vaccine neutralizing antibodies.

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Microbiology and Parasitology / Virology

Complete list of metadata

https://hal-pasteur.archives-ouvertes.fr/pasteur-03696743
Contributor : Isma Ziani Connect in order to contact the contributor
Submitted on : Thursday, June 16, 2022 - 10:56:43 AM
Last modification on : Saturday, June 25, 2022 - 3:44:22 AM

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Links full text

Identifiers

Collections

Citation

Export

Metrics

0

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

0